vast
major
smallmolecul
therapeut
clinic
use
target
protein
success
proteintarget
drug
includ
small
molecul
bind
protein
express
human
fig
express
bacteria
virus
infecti
organ
smallmolecul
therapeut
could
extend
modul
rna
landscap
target
macromolecul
would
expand
order
magnitud
exampl
roughli
human
genom
encod
within
roughli
express
human
protein
thought
mean
disrupt
alter
activ
like
therapeut
use
consequ
within
group
diseaserel
protein
mani
term
undrugg
mean
molecul
lack
distinct
cleftlik
motif
small
molecul
bind
high
specif
net
implic
analysi
de
novo
humandesign
smallmolecul
drug
target
sliver
drug
protein
sliver
human
genom
encod
protein
human
genom
current
approv
proteintarget
drug
interact
therapeut
fewer
gene
mean
human
genom
drug
fig
rna
function
central
conduit
inform
transfer
biolog
principl
numer
opportun
creat
smallmolecul
therapeut
target
rna
mrna
could
target
protein
gene
product
could
modul
upregul
downregul
translat
effici
alter
mrna
abund
stabil
directli
target
mrna
activ
protein
difficult
drug
undrugg
might
modul
biogenesi
addit
larg
fraction
human
genom
transcrib
noncod
rna
rna
function
directli
rna
fig
one
class
noncod
rna
microrna
wellvalid
therapeut
human
probabl
produc
long
noncod
subset
may
eventu
prove
good
drug
target
summari
fraction
ten
thousand
mrna
noncod
rna
target
extent
druggabl
human
genom
could
increas
consider
strong
proof
principl
rnatarget
drug
provid
experi
clinic
trial
use
antisens
oligonucleotid
sever
gain
regulatori
approv
well
preclin
studi
synthet
rna
redirect
cellular
rna
interfer
rnai
machineri
activ
crisprbas
depend
approach
employ
possibl
inhibit
upregul
particular
mrna
inhibit
noncod
rna
function
target
specif
rna
sequenc
howev
nucleicacidbas
approach
involv
larg
often
highli
charg
molecul
present
deliveri
challeng
given
choic
oligonucleotidebas
therapi
current
hypothet
smallmoleculebas
therapi
target
rna
smallmolecul
therapi
would
prefer
mani
case
number
small
molecul
alter
rna
function
identifi
provid
encourag
evid
rnatarget
smallmolecul
therapeut
could
develop
studi
base
molecul
identifi
natur
system
exampl
mani
rna
riboswitch
regulatori
element
bind
divers
smallmolecul
metabolit
regul
gene
express
smallmolecul
antibiot
produc
numer
bacteri
speci
bind
ribosom
rna
interfer
furthermor
grow
number
synthet
monoval
multival
molecul
bind
secondari
structur
element
repeatcontain
rna
shown
modul
biolog
progress
help
address
sceptic
rna
could
viabl
smallmolecul
drug
target
key
challeng
remain
address
discuss
target
rna
small
molecul
need
immedi
acknowledg
one
current
know
creat
druglik
rnatarget
small
molecul
repeat
scalabl
way
current
singl
humandesign
approv
drug
class
function
bind
rna
alon
linezolid
antibiot
linezolid
tedizolid
fig
view
success
target
rna
therapeut
use
way
small
molecul
requir
three
distinct
compon
identif
rna
rna
motif
diseaserel
function
use
screen
approach
librari
like
identifi
druglik
molecul
appropri
pharmacolog
properti
identif
focu
rna
motif
suffici
structur
sophist
make
like
high
affin
specif
smallmolecul
bind
achiev
date
work
focus
therapeut
wellvalid
target
compon
notabl
recent
focu
screen
rna
target
druglik
lead
compound
compon
howev
critic
view
consider
target
complex
achiev
select
compon
larg
neglect
mind
overview
current
state
smallmolecul
ligand
discoveri
rna
target
instruct
exampl
present
set
hypothes
regard
target
rna
small
molecul
guidelin
achiev
goal
articl
intend
provoc
look
forward
feedback
respons
idea
engend
first
reiter
one
current
know
target
rna
druglik
small
molecul
scalabl
reproduc
way
proofofprincipl
exampl
exist
fig
druglik
molecul
discov
base
phenotyp
assay
later
found
target
rna
molecul
discov
date
via
strategi
intent
design
target
rna
gener
suffer
tradeoff
druglik
potenc
due
low
inform
content
low
pocket
qualiti
nonetheless
current
exampl
support
fundament
target
rna
suspect
wide
varieti
screen
strategi
includ
phenotyp
assay
highthroughput
screen
fragmentbas
screen
smallmolecul
microarray
biophys
partit
approach
structureinspir
comput
assist
design
eventu
prove
use
light
would
like
propos
follow
guidelin
futur
effort
direct
rnatarget
drug
discoveri
focu
rna
motif
suffici
complex
uniqu
abl
form
highqual
pocket
capabl
bind
smallmolecul
ligand
high
affin
think
good
rna
target
bit
pocket
motif
like
common
larg
rna
posit
good
target
pocket
exist
absenc
high
inform
content
cautiou
earli
attempt
defin
special
privileg
chemic
scaffold
target
rna
might
exist
lot
inform
like
requir
promis
scaffold
defin
instead
emphas
rule
deriv
decad
develop
proteintarget
drug
like
appli
rnatarget
drug
well
deemphas
lesson
ribosom
due
uniqu
high
concentr
cell
ribosom
rna
special
case
engag
expect
ligand
micromolar
affin
target
present
micromolar
concentr
drug
target
ribosom
rna
thu
achiev
uniqu
kind
specif
bind
rel
weakli
ribosom
cautiou
interpret
result
studi
focus
compound
highli
basic
intercal
strongli
stack
andor
highli
hydrophob
kind
compound
may
bind
rna
high
affin
unlik
show
strong
discrimin
target
offtarget
site
like
difficult
improv
medicin
chemistri
campaign
target
interact
rna
element
stabil
protein
bind
branaplam
appear
easi
imagin
recognit
targetspecif
rna
element
conjunct
gener
protein
compon
cellular
metabol
regulatori
network
might
highli
product
strategi
achiev
specif
via
select
rnatarget
compon
affin
owe
high
inform
content
protein
interfac
use
method
enabl
rapid
identif
rna
motif
highinformationcont
structur
highqual
pocket
clear
advantag
rna
protein
tool
quantit
chemic
probe
alreadi
exist
make
possibl
identifi
structur
welldetermin
lowentropi
target
examin
influenc
cellular
environ
specif
rna
structur
ensur
simplifi
screen
construct
recapitul
nativ
rna
motif
develop
addit
tool
new
refin
current
tool
includ
advanc
structur
biolog
model
strategi
rna
complex
technolog
leverag
identifi
rapidli
character
subset
complex
rna
structur
highqual
ligandbind
pocket
rapidli
assess
impact
ligand
bind
function
site
implement
reproduc
strategi
connect
ligand
bind
complex
target
clear
therapeut
mechan
modesttogood
evid
disrupt
stabil
rna
structur
near
translat
initi
site
modul
gene
express
therapeut
use
evid
bind
small
molecul
mrna
modul
effici
disrupt
stabil
interact
therapeut
promis
coval
drug
gain
accept
proteintarget
field
analog
ligand
form
coval
linkag
induc
cleavag
rna
target
also
hold
promis
three
key
compon
necessari
enabl
effect
repeat
scalabl
rnatarget
drug
discoveri
therapeut
compel
rna
target
screen
approach
identifi
druglik
lead
molecul
appropri
pharmacolog
properti
identif
rna
motif
suffici
inform
content
highspecif
highpot
bind
highqual
pocket
achiev
argu
broad
chang
strategi
creat
rnatarget
drug
much
greater
emphasi
need
place
qualiti
rna
target
compon
biolog
wellvalid
rna
target
import
cours
much
greater
effort
need
place
ensur
ligand
target
ultim
learn
constitut
highqual
rna
target
rna
might
prove
difficult
drug
protein
inde
given
target
rna
motif
appear
ubiquit
ref
fig
e
principl
rna
structur
fold
simpler
wonder
rna
might
eventu
prove
gener
target
protein
success
rnatarget
therapeut
discoveri
effort
would
open
vast
opportun
fig
modul
function
current
undrugg
proteinmedi
pathway
noncod
transcriptom
springer
natur
remain
neutral
regard
jurisdict
claim
publish
map
institut
affili
